SCHEMBL8355467

SCHEMBL8355467

NCCCCNC(=O)C1CCCCC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.67
KEAP1 Q14145 1/20 0.58
NFE2L2 Q16236 1/20 0.58
CHRNB2 P17787 6/20 0.52
CHRNB4 P30926 6/20 0.52
CHRNA3 P32297 6/20 0.52
CHRNA4 P43681 6/20 0.52
GRIN1 Q05586 2/20 0.52
GRIN2A Q12879 2/20 0.52
GRM1 Q13255 2/20 0.52
EPHX1 P07099 1/20 0.52
ITGB3 P05106 3/20 0.50
ITGA2B P08514 3/20 0.50
GNAI3 P08754 1/20 0.49
GNAO1 P09471 1/20 0.49
GNAI1 P63096 1/20 0.49
NAMPT P43490 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PAOX Q6QHF9 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22170865 0.98 NAAA (0.70) NAAAKEAP1NFE2L2CHRNB2CHRNB4
SCHEMBL3247411 0.98 NAAA (0.70) NAAAKEAP1NFE2L2CHRNB2CHRNB4
SCHEMBL19630921 0.96 NAAA (0.67) NAAAKEAP1NFE2L2CHRNB2CHRNB4
SCHEMBL13300769 0.94 NAAA (0.64) NAAAKEAP1NFE2L2CHRNB2CHRNB4
SCHEMBL16357639 0.92 NAAA (0.61) NAAAKEAP1NFE2L2CHRNB2CHRNB4
SCHEMBL13432005 0.89 NAAA (0.56) NAAAKEAP1NFE2L2CHRNB2CHRNB4
SCHEMBL17172545 0.88 NAAA (0.82) NAAAKEAP1NFE2L2EPHX1GNAI3
Hydrochloric Acid SCHEMBL1285234 0.87 NAAA (0.54) NAAAKEAP1NFE2L2CHRNB2CHRNB4
SCHEMBL23419143 0.86 NAAA (0.58) NAAAKEAP1NFE2L2CHRNB2CHRNB4
SCHEMBL61158 0.86 NAAA (0.58) NAAAKEAP1NFE2L2CHRNB2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385870-B1 PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORP (US) 2010-03-17 EP disclosed
WO-2003062265-A2 NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2003-07-31 WO disclosed